Publication | Open Access
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma
35
Citations
31
References
2003
Year
Cyclophosphamide, prednisone, and DES represent a well tolerated, low-cost combination therapy with significant activity in the treatment of patients with AIPC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1